Page last updated: 2024-08-18

pyrazolanthrone and 2-(4-morpholinoanilino)-6-cyclohexylaminopurine

pyrazolanthrone has been researched along with 2-(4-morpholinoanilino)-6-cyclohexylaminopurine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jiang, M; Li, C; Li, J; Liang, D; Liu, J; Sun, W; Wang, S; Yang, X; Zhang, C; Zhang, M; Zhou, X	1
Qu, G; von Schroeder, HP	1
Abassi, Y; Daams, R; Fezai, M; Jemaà, M; Kifagi, C; Lang, F; Massoumi, R	1

Reviews

1 review(s) available for pyrazolanthrone and 2-(4-morpholinoanilino)-6-cyclohexylaminopurine

Article	Year
Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective. European journal of medicinal chemistry, 2019, Aug-01, Volume: 175 Topics: Antineoplastic Agents; Cell Cycle Proteins; Drug Design; Drug Resistance; Humans; M Phase Cell Cycle Checkpoints; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Spindle Apparatus; Structure-Activity Relationship; Triple Negative Breast Neoplasms	2019

Article

Year

Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective.

European journal of medicinal chemistry, 2019, Aug-01, Volume: 175

Topics: Antineoplastic Agents; Cell Cycle Proteins; Drug Design; Drug Resistance; Humans; M Phase Cell Cycle Checkpoints; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Spindle Apparatus; Structure-Activity Relationship; Triple Negative Breast Neoplasms

2019

Other Studies

2 other study(ies) available for pyrazolanthrone and 2-(4-morpholinoanilino)-6-cyclohexylaminopurine

Article	Year
Preliminary evidence for the dedifferentiation of RAW 264.7 cells into mesenchymal progenitor-like cells by a purine analog. Tissue engineering. Part A, 2012, Volume: 18, Issue:17-18 Topics: Adipogenesis; Animals; Anthracenes; Antigens, Surface; Bone and Bones; Carbocyanines; Cell Dedifferentiation; Cell Line; Endoglin; Flow Cytometry; Humans; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Macrophages; Mesenchymal Stem Cells; Mice; Microscopy, Fluorescence; Morpholines; Protein Kinase Inhibitors; Purines; Rats; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Tissue Scaffolds; X-Ray Microtomography	2012
Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1. Scientific reports, 2018, 08-07, Volume: 8, Issue:1 Topics: Animals; Anthracenes; Cell Line; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Humans; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mitogen-Activated Protein Kinase 8; Molecular Targeted Therapy; Morpholines; Purines; Tumor Burden; Xenograft Model Antitumor Assays	2018

Article

Year

Preliminary evidence for the dedifferentiation of RAW 264.7 cells into mesenchymal progenitor-like cells by a purine analog.

Tissue engineering. Part A, 2012, Volume: 18, Issue:17-18

Topics: Adipogenesis; Animals; Anthracenes; Antigens, Surface; Bone and Bones; Carbocyanines; Cell Dedifferentiation; Cell Line; Endoglin; Flow Cytometry; Humans; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Macrophages; Mesenchymal Stem Cells; Mice; Microscopy, Fluorescence; Morpholines; Protein Kinase Inhibitors; Purines; Rats; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Tissue Scaffolds; X-Ray Microtomography

2012

Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1.

Scientific reports, 2018, 08-07, Volume: 8, Issue:1

Topics: Animals; Anthracenes; Cell Line; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Humans; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mitogen-Activated Protein Kinase 8; Molecular Targeted Therapy; Morpholines; Purines; Tumor Burden; Xenograft Model Antitumor Assays

2018